GT Biopharma Inc. (GTBP) Hits New 2018 High
GT Biopharma (GTBP) has been on our radar for months now and with several key catalysts including a potential Nasdaq Uplisting that could be coming up in the near future, 2018 could be setting up to become a VERY strong year
Could Big Pharma Use Blockchain Technology To Save More People
That’s the thinking ongoing at pharmaceutical heavyweights Pfizer, Amgen and Sanofi. The three companies – typically black boxes when it comes to their work – are now eyeing blockchain as a means of streamlining the process of developing and testing new drugs. Speaking exclusively to CoinDesk, representatives from the companies shed light on how they are combining efforts to develop a blockchain framework that can address current logjams in the clinical trials process.
Two Power House Companies Are Working on AI-Enabled Immunology
Microsoft and Seattle-based immuno-sequencing company Adaptive Biotechnologies on Jan. 4 announced great news to the public about a collaborative partnership that will bring artificial intelligence to bear on early detection of cancer and other diseases.
An affiliate of BIOTECHSTOCKS,.com MAPH ENTERPRISES LLC., a Florida Corporation that has been compensated $150,000.00 by a GT Biopharma Inc. for a period beginning Jan 1, 2018 and ending Feb. 1, 2018 to publicly disseminate information about (GTBP). We own zero shares. Full Disclaimer